Table 4. Study Arms in the NCI-N87 Second Run.
group | N | agent | mg/kg |
---|---|---|---|
1 | 10 | vehicle | |
2 | 10 | trastuzumab-deruxtecan (enhertu) | 2.5 |
3 | 10 | trastuzumab-deruxtecan (enhertu) | 1.25 |
4 | 10 | ADC 7 (AJICAP, APL-1092) | 10 |
5 | 10 | ADC 7 (AJICAP, APL-1092) | 5.0 |
6 | 10 | ADC 7 (AJICAP, APL-1092) | 2.5 |
7 | 10 | ADC 9 (interchain-break, APL-1092) | 2.5 |
8 | 10 | ADC 9 (interchain-break, APL-1092) | 1.25 |